LIMN peer analysis
LIMN (LIMN) against its competitors: price, today's move, 1-year return and market value side by side.
- LIMN's peers: ATHE (Alterity Therapeutics), DYAI (Dyadic International), EVAX (Evaxion Biotech A/S), JSPR (Jasper Therapeutics), MAIA (MAIA Biotechnology), NNVC (NanoViricides), SABS (SAB Biotherapeutics).
LIMN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ATHE Alterity Therapeutics | $1.66 | -2.65% | -54.41% | $28.04M |
| DYAI Dyadic International | $0.31 | -2.91% | -66.52% | $12.46M |
| EVAX Evaxion Biotech A/S | $2.03 | -20.08% | -58.40% | $12.82M |
| JSPR Jasper Therapeutics | $10.75 | -6.68% | -80.63% | $11.92M |
| MAIA MAIA Biotechnology | $1.14 | -12.31% | 23.91% | $70.40M |
| NNVC NanoViricides | $1.17 | -1.68% | -17.02% | $29.90M |
| SABS SAB Biotherapeutics | $2.82 | -3.09% | -26.37% | $254.05M |
| LIMN Liminatus Pharma | $2.81 | 4.85% | -94.98% | $188.72M |